Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19
(Genetic Technologies Ltd Wed, November 18, 2020, 12:30 AM GMT+11)
MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr. Jerzy Muchnicki, will share insight into the company’s recent developments during an investor webinar on Thursday, November 19, 2020 at 4:15 p.m. ET. A live Q&A session with Dr. Muchnicki will follow the presentation.To participate in the webinar, please register at: https://www.redchip.com/corporate/webinar_register/78Questions can be pre-submitted to [email protected] or on the website during the event.
